{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T07:28:08Z","timestamp":1771054088468,"version":"3.50.1"},"reference-count":129,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2019,1,15]],"date-time":"2019-01-15T00:00:00Z","timestamp":1547510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["2016YFA0501703"],"award-info":[{"award-number":["2016YFA0501703"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006407","name":"Natural Science Foundation of Henan Province","doi-asserted-by":"publisher","award":["162300410060"],"award-info":[{"award-number":["162300410060"]}],"id":[{"id":"10.13039\/501100006407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003489","name":"Henan University of Technology","doi-asserted-by":"publisher","award":["21450004"],"award-info":[{"award-number":["21450004"]}],"id":[{"id":"10.13039\/501100003489","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2018M632766"],"award-info":[{"award-number":["2018M632766"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>The human papillomavirus (HPV) 58 is considered to be the second most predominant genotype in cervical cancer incidents in China. HPV type-restriction, non-targeted delivery, and the highcost of existing vaccines necessitate continuing research on the HPV vaccine. We aimed to explore the papillomaviral proteome in order to identify potential candidates for a chimeric vaccine against cervix papilloma using computational immunology and structural vaccinology approaches. Two overlapped epitope segments (23\u201336) and (29\u201342) from the N-terminal region of the HPV58 minor capsid protein L2 are selected as capable of inducing both cellular and humoral immunity. In total, 318 amino acid lengths of the vaccine construct SGD58 contain adjuvants (Flagellin and RS09), two Th epitopes, and linkers. SGD58 is a stable protein that is soluble, antigenic, and non-allergenic. Homology modeling and the structural refinement of the best models of SGD58 and TLR5 found 96.8% and 93.9% favored regions in Rampage, respectively. The docking results demonstrated a HADDOCK score of \u221262.5 \u00b1 7.6, the binding energy (\u221230 kcal\/mol) and 44 interacting amino acid residues between SGD58-TLR5 complex. The docked complex are stable in 100 ns of simulation. The coding sequences of SGD58 also show elevated gene expression in Escherichia coli with 1.0 codon adaptation index and 59.92% glycine-cysteine content. We conclude that SGD58 may prompt the creation a vaccine against cervix papilloma.<\/jats:p>","DOI":"10.3390\/v11010063","type":"journal-article","created":{"date-parts":[[2019,1,16]],"date-time":"2019-01-16T03:09:13Z","timestamp":1547608153000},"page":"63","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Exploring the Papillomaviral Proteome to Identify Potential Candidates for a Chimeric Vaccine against Cervix Papilloma Using Immunomics and Computational Structural Vaccinology"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3604-8810","authenticated-orcid":false,"given":"Satyavani","family":"Kaliamurthi","sequence":"first","affiliation":[{"name":"Center of Interdisciplinary Science-Computational Life Sciences, College of Food Science and Engineering, Henan University of Technology, Zhengzhou 450001, China"},{"name":"College of Chemistry, Chemical Engineering and Environment, Henan University of Technology, Zhengzhou 450001, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7223-3853","authenticated-orcid":false,"given":"Gurudeeban","family":"Selvaraj","sequence":"additional","affiliation":[{"name":"Center of Interdisciplinary Science-Computational Life Sciences, College of Food Science and Engineering, Henan University of Technology, Zhengzhou 450001, China"},{"name":"College of Chemistry, Chemical Engineering and Environment, Henan University of Technology, Zhengzhou 450001, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sathishkumar","family":"Chinnasamy","sequence":"additional","affiliation":[{"name":"The State Key Laboratory of Microbial Metabolism, College of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai 200240, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiankun","family":"Wang","sequence":"additional","affiliation":[{"name":"The State Key Laboratory of Microbial Metabolism, College of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai 200240, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asma Sindhoo","family":"Nangraj","sequence":"additional","affiliation":[{"name":"The State Key Laboratory of Microbial Metabolism, College of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai 200240, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4174-4586","authenticated-orcid":false,"given":"William CS","family":"Cho","sequence":"additional","affiliation":[{"name":"Department of Clinical Oncology, Queen Elizabeth Hospital, Kowloon, Hong Kong"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keren","family":"Gu","sequence":"additional","affiliation":[{"name":"Center of Interdisciplinary Science-Computational Life Sciences, College of Food Science and Engineering, Henan University of Technology, Zhengzhou 450001, China"},{"name":"College of Chemistry, Chemical Engineering and Environment, Henan University of Technology, Zhengzhou 450001, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4200-7502","authenticated-orcid":false,"given":"Dong-Qing","family":"Wei","sequence":"additional","affiliation":[{"name":"Center of Interdisciplinary Science-Computational Life Sciences, College of Food Science and Engineering, Henan University of Technology, Zhengzhou 450001, China"},{"name":"The State Key Laboratory of Microbial Metabolism, College of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai 200240, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2019,1,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.4049\/jimmunol.1490012","article-title":"Development and implementation of papillomavirus prophylactic vaccines","volume":"192","author":"Frazer","year":"2014","journal-title":"J. Immunol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.virusres.2009.06.008","article-title":"Oncogenic activities of human papillomaviruses","volume":"143","author":"Munger","year":"2009","journal-title":"Virus Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.virol.2010.02.002","article-title":"Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments","volume":"401","author":"Bernard","year":"2010","journal-title":"Virology"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Fauquet, C.M., Mayo, M.A., Maniloff, J., Desselberger, U., and Ball, LA. (2005). Family Papillomaviridae. Virus Taxonomy. The Eighth Report of the International Committee on Taxonomy of Viruses, Elsevier.","DOI":"10.1016\/B978-0-12-249951-7.50004-3"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.radonc.2013.06.004","article-title":"Human papillomaviruses and cancer","volume":"108","author":"Haedicke","year":"2013","journal-title":"Radiother. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00705-017-3556-1","article-title":"Human papillomavirus genotype distribution among HPV-positive women in Sichuan province, Southwest China","volume":"163","author":"Tao","year":"2018","journal-title":"Arch. Virol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/jama.297.8.813","article-title":"Prevalence of HPV infection among females in the United States","volume":"297","author":"Dunne","year":"2007","journal-title":"JAMA"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1158\/1078-0432.CCR-07-1881","article-title":"Phase I immunotherapeutic trial with long peptides spanning the E6 and E7 sequences of high-risk human papillomavirus 16 in end-stage cervical cancer patients shows low toxicity and robust immunogenicity","volume":"14","author":"Kenter","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1007\/s00262-012-1292-7","article-title":"A placebo-controlled randomized HPV16 synthetic long-peptide vaccination study in women with high-grade cervical squamous intraepithelial lesions","volume":"61","author":"Ramwadhdoebe","year":"2012","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_10","first-page":"441","article-title":"Cervical Cancer Screening","volume":"97","author":"Rerucha","year":"2018","journal-title":"Am. Fam. Physician"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Hong, Y., Zhang, C., Li, X., Lin, D., and Liu, Y. (2013). HPV and cervical cancer related knowledge, awareness and testing behaviors in a community sample of female sex workers in China. BMC Public Health, 13.","DOI":"10.1186\/1471-2458-13-696"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3322\/caac.21338","article-title":"Cancer statistics in China, 2015","volume":"66","author":"Chen","year":"2016","journal-title":"CA Cancer J. Clin."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.jinf.2018.02.008","article-title":"Prevalence and distribution of human papillomavirus genotypes in Chinese women between 1991 and 2016: A systematic review","volume":"76","author":"Zhou","year":"2018","journal-title":"J. Infect."},{"key":"ref_14","first-page":"412","article-title":"Epidemiological study of high-risk human papillomavirus infection in subjects with abnormal cytological findings in cervical cancer screening","volume":"15","author":"You","year":"2018","journal-title":"Exp. Ther. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12985-018-1003-x","article-title":"HPV-16, HPV-58, and HPV-33 are the most carcinogenic HPV genotypes in Southwestern China and their viral loads are associated with severity of premalignant lesions in the cervix","volume":"15","author":"Long","year":"2018","journal-title":"Virol. J."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Zhang, C., Huang, C., Zheng, X., and Pan, D. (2018). Prevalence of human papillomavirus among Wenzhou women diagnosed with cervical intraepithelial neoplasia and cervical cancer. Infect. Agent. Cancer, 13.","DOI":"10.1186\/s13027-018-0211-8"},{"key":"ref_17","first-page":"e22581","article-title":"Distribution characteristics of different human papillomavirus genotypes in women in Wuhan, China","volume":"32","author":"Dai","year":"2018","journal-title":"Cancer Med."},{"key":"ref_18","first-page":"204","article-title":"Prevalence and genotype distribution of human papillomavirus infection among women in northeastern Guangdong Province of China","volume":"18","author":"Zhao","year":"2018","journal-title":"J. Clin. Lab. Anal."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Liu, S., Zhong, Z., Hou, J., Lin, L., Weng, R., Su, L., Lei, N., Hou, T., Yang, H., and Li, K. (2017). Analysis of HPV distribution in patients with cervical precancerous lesions in Western China. BMC Infect. Dis., 96.","DOI":"10.1097\/MD.0000000000007304"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"912","DOI":"10.12659\/MSM.905789","article-title":"The Genotype of Human Papillomavirus and Associated Factors Among High Risk Males in Shanghai, China: A Molecular Epidemiology Study","volume":"24","author":"Zhang","year":"2018","journal-title":"Med. Sci. Monit."},{"key":"ref_21","unstructured":"(2010). FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP). MMWR Morb. Mortal. Wkly. Rep., 59, 626\u2013629."},{"key":"ref_22","unstructured":"(2011). Recommendations on the use of quadrivalent human papillomavirus vaccine in males--Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb. Mortal. Wkly. Rep., 60, 1705\u20131708."},{"key":"ref_23","first-page":"300","article-title":"Use of 9-valent human papillomavirus (HPV) vaccine: Updated HPV vaccination recommendations of the advisory committee on immunization practices","volume":"64","author":"Petrosky","year":"2015","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Paz-Zulueta, M., Alvarez-Paredes, L., Rodriguez Diaz, J.C., Paras-Bravo, P., Andrada Becerra, M.E., Rodriguez Ingelmo, J.M., Ruiz Garcia, M.M., Portilla, J., and Santibanez, M. (2018). Prevalence of high-risk HPV genotypes, categorised by their quadrivalent and nine-valent HPV vaccination coverage, and the genotype association with high-grade lesions. BMC Cancer, 18.","DOI":"10.1186\/s12885-018-4033-2"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1586\/14760584.2016.1157479","article-title":"Progress and prospects for L2-based human papillomavirus vaccines","volume":"15","author":"Jiang","year":"2016","journal-title":"Expert Rev. Vaccines"},{"key":"ref_26","first-page":"531","article-title":"Virus-like particles as vaccine","volume":"61","author":"Chroboczek","year":"2014","journal-title":"ActaBiochim. Pol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4103\/0253-7184.85409","article-title":"Human papilloma virus vaccines: Current scenario","volume":"32","author":"Pandhi","year":"2011","journal-title":"Indian J. Sex Transm. Dis. AIDS"},{"key":"ref_28","first-page":"97","article-title":"Cervarix: A vaccine for the prevention of HPV 16, 18-associated cervical cancer","volume":"2","author":"Monie","year":"2008","journal-title":"Biologics"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.critrevonc.2016.03.020","article-title":"Ten years of HPV vaccines: State of art and controversies","volume":"102","author":"Angioli","year":"2016","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/icb.2009.13","article-title":"Developing vaccines against minor capsid antigen L2 to prevent papillomavirus infection","volume":"87","author":"Karanam","year":"2009","journal-title":"Immunol. Cell Biol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e217","DOI":"10.1016\/S1470-2045(14)71179-9","article-title":"Next generation prophylactic human papillomavirus vaccines","volume":"16","author":"Schiller","year":"2015","journal-title":"Lancet Oncol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.virol.2013.04.017","article-title":"L2, the minor capsid protein of papillomavirus","volume":"445","author":"Wang","year":"2013","journal-title":"Virology"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1006\/viro.1995.1392","article-title":"Vaccination of cattle with the N-terminus of L2 is necessary and sufficient for preventing infection by bovine papillomavirus-4","volume":"211","author":"Chandrachud","year":"1995","journal-title":"Virology"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1099\/0022-1317-77-7-1577","article-title":"Vaccination of cattle with bovine papillomavirus type 4 L2 elicits the production of virus-neutralizing antibodies","volume":"77 (Pt 7)","author":"Gaukroger","year":"1996","journal-title":"J. Gen. Virol."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"(2017). UniProt: The universal protein knowledgebase. Nucleic Acids Res., 45, D158\u2013D169.","DOI":"10.1093\/nar\/gkw1099"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1744-313X.2006.00637.x","article-title":"Allelic distribution of HLA class I genes in the Tibetan ethnic population of China","volume":"33","author":"Chen","year":"2006","journal-title":"Int. J. Immunogenet."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.humimm.2007.02.006","article-title":"Origin of Tibeto-Burman speakers: Evidence from HLA allele distribution in Lisu and Nu inhabiting Yunnan of China","volume":"68","author":"Chen","year":"2007","journal-title":"Hum. Immunol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.humimm.2007.09.006","article-title":"Human leukocyte antigen class I polymorphism in Miao, Bouyei, and Shui ethnic minorities of Guizhou, China","volume":"68","author":"Chen","year":"2007","journal-title":"Hum. Immunol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"7333","DOI":"10.7314\/APJCP.2014.15.17.7333","article-title":"Prevalence and genotype distribution of human papillomavirus among women from Henan, China","volume":"15","author":"Wang","year":"2014","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/s12985-014-0202-3","article-title":"The diversity of human papillomavirus infection among human immunodeficiency virus-infected women in Yunnan, China","volume":"11","author":"Zhang","year":"2014","journal-title":"Virol. J."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Lu, J.F., Shen, G.R., Li, Q., Chen, X., Ma, C.F., and Zhu, T.H. (2017). Genotype distribution characteristics of multiple human papillomavirus in women from the Taihu River Basin, on the coast of eastern China. BMC Infect. Dis., 17.","DOI":"10.1186\/s12879-017-2328-6"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Wang, Y., and Xue, J. (2018). Distribution and role of high-risk human papillomavirus genotypes in women with cervical intraepithelial neoplasia: A retrospective analysis from Wenzhou, southeast China. Cancer Med.","DOI":"10.1002\/cam4.1559"},{"key":"ref_43","first-page":"D405","article-title":"The immune epitope database (IEDB) 3.0","volume":"43","author":"Dai","year":"2015","journal-title":"Cancer Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/nbt1215","article-title":"A consensus epitope prediction approach identifies the breadth of murine T(CD8+)-cell responses to vaccinia virus","volume":"24","author":"Moutaftsi","year":"2006","journal-title":"Nat. Biotechnol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1110\/ps.0239403","article-title":"Reliable prediction of T-cell epitopes using neural networks with novel sequence representations","volume":"12","author":"Nielsen","year":"2003","journal-title":"Protein Sci."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1016\/j.vaccine.2004.02.005","article-title":"Prediction of CTL epitopes using QM, SVM and ANN techniques","volume":"22","author":"Bhasin","year":"2004","journal-title":"Vaccine"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"W254","DOI":"10.1093\/nar\/gkr434","article-title":"PAComplex: A web server to infer peptide antigen families and binding models from TCR-pMHC complexes","volume":"39","author":"Liu","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Wang, P., Sidney, J., Dow, C., Mothe, B., Sette, A., and Peters, B. (2008). A systematic assessment of MHC class II peptide binding predictions and evaluation of a consensus approach. PLoS Comput. Biol., 4.","DOI":"10.1371\/journal.pcbi.1000048"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/cpim.12","article-title":"TepiTool: A Pipeline for Computational Prediction of T Cell Epitope Candidates","volume":"114","author":"Paul","year":"2016","journal-title":"Curr. Protoc. Immunol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1745-6150-8-30","article-title":"Designing of interferon-gamma inducing MHC class-II binders","volume":"8","author":"Dhanda","year":"2013","journal-title":"Biol. Direct"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/prot.21078","article-title":"Prediction of continuous B-cell epitopes in an antigen using recurrent neural network","volume":"65","author":"Saha","year":"2006","journal-title":"Proteins"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1007\/s00894-014-2278-5","article-title":"AllerTOP v.2\u2014A server for in silico prediction of allergens","volume":"20","author":"Dimitrov","year":"2014","journal-title":"J. Mol. Model."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1093\/bioinformatics\/btt619","article-title":"Allergen FP: Allergenicity prediction by descriptor fingerprints","volume":"30","author":"Dimitrov","year":"2014","journal-title":"Bioinformatics"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"El-Manzalawy, Y., Dobbs, D., and Honavar, V. (2012, January 7\u201310). Predicting protective bacterial antigens using random forest classifiers. Proceedings of the ACM Conference on Bioinformatics, Computational Biology and Biomedicine, Orlando, FL, USA.","DOI":"10.1145\/2382936.2382991"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.1093\/bioinformatics\/btt484","article-title":"A fast Peptide Match service for UniProt Knowledgebase","volume":"29","author":"Chen","year":"2013","journal-title":"Bioinformatics"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Bui, H.H., Sidney, J., Li, W., Fusseder, N., and Sette, A. (2007). Development of an epitope conservancy analysis tool to facilitate the design of epitope-based diagnostics and vaccines. BMC Bioinform., 8.","DOI":"10.1186\/1471-2105-8-361"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1093\/molbev\/msw054","article-title":"MEGA7: Molecular Evolutionary Genetics Analysis Version 7.0 for Bigger Datasets","volume":"33","author":"Kumar","year":"2016","journal-title":"Mol. Biol. Evol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1093\/bioinformatics\/btp386","article-title":"SOLpro: Accurate sequence-based prediction of protein solubility","volume":"25","author":"Magnan","year":"2009","journal-title":"Bioinformatics"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Walker, J.M. (2005). Protein Identification and Analysis Tools on the ExPASy Server. The Proteomics Protocols Handbook, Humana Press.","DOI":"10.1385\/1592598900"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Doytchinova, I.A., and Flower, D.R. (2007). VaxiJen: A server for prediction of protective antigens, tumour antigens and subunit vaccines. BMC Bioinform., 8.","DOI":"10.1186\/1471-2105-8-4"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Zhang, Y. (2008). I-TASSER server for protein 3D structure prediction. BMC Bioinform., 9.","DOI":"10.1186\/1471-2105-9-40"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"W526","DOI":"10.1093\/nar\/gkh468","article-title":"Protein structure prediction and analysis using the Robetta server","volume":"32","author":"Kim","year":"2004","journal-title":"Nucleic Acids Res."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"W294","DOI":"10.1093\/nar\/gks493","article-title":"GalaxyWEB server for protein structure prediction and refinement","volume":"40","author":"Ko","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Bhattacharya, D., and Cheng, J. (2013). i3Drefine software for protein 3D structure refinement and its assessment in CASP10. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0069648"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"W407","DOI":"10.1093\/nar\/gkm290","article-title":"ProSA-web: Interactive web service for the recognition of errors in three-dimensional structures of proteins","volume":"35","author":"Wiederstein","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/prot.10286","article-title":"Structure validation by Calpha geometry: phi, psi and Cbeta deviation","volume":"50","author":"Lovell","year":"2003","journal-title":"Proteins"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1002\/pro.5560020916","article-title":"Verification of protein structures: Patterns of nonbonded atomic interactions","volume":"2","author":"Colovos","year":"1993","journal-title":"Protein Sci."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Kringelum, J.V., Lundegaard, C., Lund, O., and Nielsen, M. (2012). Reliable B cell epitope predictions: Impacts of method development and improved benchmarking. PLoS Comput. Biol., 8.","DOI":"10.1371\/journal.pcbi.1002829"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jmb.2015.09.014","article-title":"The HADDOCK2.2 Web Server: User-Friendly Integrative Modeling of Biomolecular Complexes","volume":"428","author":"Rodrigues","year":"2016","journal-title":"J. Mol. Biol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/protein\/8.2.127","article-title":"LIGPLOT: A program to generate schematic diagrams of protein-ligand interactions","volume":"8","author":"Wallace","year":"1996","journal-title":"Protein Eng."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/prot.24200","article-title":"Structural features of cholesteryl ester transfer protein: A molecular dynamics simulation study","volume":"81","author":"Lei","year":"2013","journal-title":"Proteins"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1107\/S0907444904011679","article-title":"PRODRG: A tool for high-throughput crystallography of protein-ligand complexes","volume":"60","author":"Schuttelkopf","year":"2004","journal-title":"ActaCrystallogr. D Biol. Crystallogr."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1039\/C3MB70305C","article-title":"Molecular insights on TNKS1\/TNKS2 and inhibitor-IWR1 interactions","volume":"10","author":"Kirubakaran","year":"2014","journal-title":"Mol. Biosyst."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S0168-9525(00)02024-2","article-title":"EMBOSS: The European Molecular Biology Open Software Suite","volume":"16","author":"Rice","year":"2000","journal-title":"Trends Genet."},{"key":"ref_75","unstructured":"(2018, October 01). The GenScript Rare Codon Analysis. Available online: https:\/\/www.genscript.com\/tools\/rare-codon-analysis."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"40878","DOI":"10.1038\/srep40878","article-title":"A conserved TLR5 binding and activation hot spot on flagellin","volume":"7","author":"Song","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1126\/science.1215584","article-title":"Structural basis of TLR5-flagellin recognition and signaling","volume":"335","author":"Yoon","year":"2012","journal-title":"Science"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.meegid.2017.08.002","article-title":"A novel HPV prophylactic peptide vaccine, designed by immunoinformatics and structural vaccinology approaches","volume":"54","author":"Negahdaripour","year":"2017","journal-title":"Infect. Genet. Evol."},{"key":"ref_79","first-page":"107","article-title":"Designing of CD8(+) and CD8(+)-overlapped CD4(+) epitope vaccine by targeting late and early proteins of human papillomavirus","volume":"12","author":"Kaliamurthi","year":"2018","journal-title":"Biologics"},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Khan, A., Junaid, M., Kaushik, A.C., Ali, A., Ali, S.S., Mehmood, A., and Wei, D.Q. (2018). Computational identification, characterization and validation of potential antigenic peptide vaccines from hrHPVs E6 proteins using immunoinformatics and computational systems biology approaches. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0196484"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s12539-017-0270-3","article-title":"Rare Diseases: Drug Discovery and Informatics Resource","volume":"10","author":"Zhao","year":"2018","journal-title":"Interdiscip. Sci."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s12539-016-0184-5","article-title":"Designing of Epitope-Focused Vaccine by Targeting E6 and E7 Conserved Protein Sequences: An Immuno-Informatics Approach in Human Papillomavirus 58 Isolates","volume":"10","author":"Sabah","year":"2018","journal-title":"Interdiscip. Sci."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Kaliamurthi, S., Selvaraj, G., Junaid, M., Khan, A., Gu, K., and Wei, D.Q. (2018). Cancer Immunoinformatics: A Promising Era in the Development of Peptide Vaccines for Human Papillomavirus induced Cervical cancer. Curr. Pharm. Des.","DOI":"10.2174\/1381612824666181106094133"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/nrd2224","article-title":"More than one reason to rethink the use of peptides in vaccine design","volume":"6","author":"Purcell","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Bywaters, S.M., Brendle, S.A., Tossi, K.P., Biryukov, J., Meyers, C., and Christensen, N.D. (2017). Antibody Competition Reveals Surface Location of HPV L2 Minor Capsid Protein Residues 17-36. Viruses, 9.","DOI":"10.3390\/v9110336"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"5190","DOI":"10.1128\/JVI.02726-07","article-title":"Arrangement of L2 within the papillomavirus capsid","volume":"82","author":"Buck","year":"2008","journal-title":"J. Virol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"4818","DOI":"10.1128\/JVI.77.8.4818-4826.2003","article-title":"Interactions between papillomavirus L1 and L2 capsid proteins","volume":"77","author":"Finnen","year":"2003","journal-title":"J. Virol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1099\/0022-1317-76-5-1141","article-title":"Human papillomavirus type 16 capsids expose multiple type-restricted and type-common antigenic epitopes","volume":"76","author":"Heino","year":"1995","journal-title":"J. Gen. Virol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"12546","DOI":"10.1074\/jbc.M208691200","article-title":"Interaction of L2 with beta-actin directs intracellular transport of papillomavirus and infection","volume":"278","author":"Yang","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"13447","DOI":"10.1128\/JVI.78.24.13447-13454.2004","article-title":"The positively charged termini of L2 minor capsid protein required for bovine papillomavirus infection function separately in nuclear import and DNA binding","volume":"78","author":"Fay","year":"2004","journal-title":"J. Virol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1073\/pnas.0508815103","article-title":"Cleavage of the papillomavirus minor capsid protein, L2, at a furin consensus site is necessary for infection","volume":"103","author":"Richards","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1586\/14760584.2014.865523","article-title":"Second-generation prophylactic HPV vaccines: Successes and challenges","volume":"13","author":"Tyler","year":"2014","journal-title":"Expert Rev. Vaccines"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"11585","DOI":"10.1128\/JVI.01577-07","article-title":"Protection of rabbits against challenge with rabbit papillomaviruses by immunization with the N terminus of human papillomavirus type 16 minor capsid antigen L2","volume":"81","author":"Gambhira","year":"2007","journal-title":"J. Virol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.virol.2010.10.017","article-title":"The N-terminal region of the human papillomavirus L2 protein contains overlapping binding sites for neutralizing, cross-neutralizing and non-neutralizing antibodies","volume":"409","author":"Rubio","year":"2011","journal-title":"Virology"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S0264-410X(96)00183-1","article-title":"Adjuvants\u2014A classification and review of their modes of action","volume":"15","author":"Cox","year":"1997","journal-title":"Vaccine"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/nri2510","article-title":"Towards an understanding of the adjuvant action of aluminium","volume":"9","author":"Marrack","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1128\/CVI.00105-10","article-title":"T-cell response to human papillomavirus type 58 L1, E6, And E7 peptides in women with cleared infection, cervical intraepithelial neoplasia, or invasive cancer","volume":"17","author":"Chan","year":"2010","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/978-1-4615-1823-5_10","article-title":"MF59. Design and evaluation of a safe and potent adjuvant for human vaccines","volume":"6","author":"Ott","year":"1995","journal-title":"Pharm. Biotechnol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"5850","DOI":"10.1073\/pnas.0800868105","article-title":"Protection against heterologous human papillomavirus challenge by a synthetic lipopeptide vaccine containing a broadly cross-neutralizing epitope of L2","volume":"105","author":"Alphs","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.vaccine.2006.08.013","article-title":"Vaccination with recombinant fusion proteins incorporating Toll-like receptor ligands induces rapid cellular and humoral immunity","volume":"25","author":"Huleatt","year":"2007","journal-title":"Vaccine"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"5677","DOI":"10.4049\/jimmunol.1002156","article-title":"Flagellin as an adjuvant: Cellular mechanisms and potential","volume":"185","author":"Mizel","year":"2010","journal-title":"J. Immunol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"6186","DOI":"10.4049\/jimmunol.0901474","article-title":"AS04, an aluminum salt- and TLR4 agonist-based adjuvant system, induces a transient localized innate immune response leading to enhanced adaptive immunity","volume":"183","author":"Didierlaurent","year":"2009","journal-title":"J. Immunol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"4792","DOI":"10.1016\/j.vaccine.2017.11.089","article-title":"Immunogenicity of HPV prophylactic vaccines: Serology assays and their use in HPV vaccine evaluation and development","volume":"36","author":"Pinto","year":"2018","journal-title":"Vaccine"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/cam4.869","article-title":"Efficacy, immunogenicity, and safety of the HPV-16\/18 AS04-adjuvanted vaccine in Chinese women aged 18\u201325 years: Event-triggered analysis of a randomized controlled trial","volume":"6","author":"Zhu","year":"2017","journal-title":"Cancer Med."},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Shanmugam, A., Rajoria, S., George, A.L., Mittelman, A., Suriano, R., and Tiwari, R.K. (2012). Synthetic Toll like receptor-4 (TLR-4) agonist peptides as a novel class of adjuvants. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0030839"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.coi.2016.06.007","article-title":"The science of vaccine adjuvants: Advances in TLR4 ligand adjuvants","volume":"41","author":"Reed","year":"2016","journal-title":"Curr. Opin. Immunol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S1074-7613(94)80017-0","article-title":"Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides","volume":"1","author":"Alexander","year":"1994","journal-title":"Immunity"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.imlet.2004.01.006","article-title":"The pan HLA DR-binding epitope improves adjuvant-assisted immunization with a recombinant protein containing a malaria vaccine candidate","volume":"92","author":"Rosa","year":"2004","journal-title":"Immunol. Lett."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00002371-200003000-00010","article-title":"Detection of T helper responses, but not of human papillomavirus-specific cytotoxic T lymphocyte responses, after peptide vaccination of patients with cervical carcinoma","volume":"23","author":"Ressing","year":"2000","journal-title":"J. Immunother."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1423-0127-17-88","article-title":"Improving therapeutic HPV peptide-based vaccine potency by enhancing CD4+ T help and dendritic cell activation","volume":"17","author":"Wu","year":"2010","journal-title":"J. Biomed. Sci."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"5235","DOI":"10.1016\/j.vaccine.2006.03.079","article-title":"Eradication of established HPV 16-expressing tumors by a single administration of a vaccine composed of a liposome-encapsulated CTL-T helper fusion peptide in a water-in-oil emulsion","volume":"24","author":"Daftarian","year":"2006","journal-title":"Vaccine"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.1016\/j.vaccine.2014.02.024","article-title":"Generation of a universal CD4 memory T cell recall peptide effective in humans, mice and non-human primates","volume":"32","author":"Fraser","year":"2014","journal-title":"Vaccine"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00253-015-6985-3","article-title":"Construction of a linker library with widely controllable flexibility for fusion protein design","volume":"100","author":"Li","year":"2016","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.biotechadv.2014.11.005","article-title":"Synthetic fusion protein design and applications","volume":"33","author":"Yu","year":"2015","journal-title":"Biotechnol. Adv."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"6565","DOI":"10.1021\/acs.biochem.7b00902","article-title":"Tuning the Flexibility of Glycine-Serine Linkers to Allow Rational Design of Multidomain Proteins","volume":"56","author":"Krom","year":"2017","journal-title":"Biochemistry"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"8727434","DOI":"10.1155\/2017\/8727434","article-title":"Identification and Characterization of a Splicing Variant in the 5\u2019 UTR of the Human TLR5 Gene","volume":"2017","author":"Hoang","year":"2017","journal-title":"BioMed Res. Int."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.cell.2010.01.022","article-title":"Pattern recognition receptors and inflammation","volume":"140","author":"Takeuchi","year":"2010","journal-title":"Cell"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S1471-4906(03)00242-4","article-title":"Leucine-rich repeats and pathogen recognition in Toll-like receptors","volume":"24","author":"Bell","year":"2003","journal-title":"Trends Immunol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S0952-7915(03)00080-3","article-title":"Recognition of microbial infection by Toll-like receptors","volume":"15","author":"Kopp","year":"2003","journal-title":"Curr. Opin. Immunol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1525-1438.2007.01008.x","article-title":"Increased expression of Toll-like receptor 5 during progression of cervical neoplasia","volume":"18","author":"Kim","year":"2008","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/apm.12707","article-title":"Polymorphism of TLR5 rs5744174 is associated with disease progression in Chinese patients with chronic HBV infection","volume":"125","author":"Cao","year":"2017","journal-title":"Apmis"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1016\/j.vaccine.2014.04.032","article-title":"Low doses of flagellin-L2 multimer vaccines protect against challenge with diverse papillomavirus genotypes","volume":"32","author":"Kalnin","year":"2014","journal-title":"Vaccine"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"7009","DOI":"10.4049\/jimmunol.167.12.7009","article-title":"Salmonella flagellin-dependent proinflammatory responses are localized to the conserved amino and carboxyl regions of the protein","volume":"167","author":"Wong","year":"2001","journal-title":"J. Immunol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"5667","DOI":"10.1074\/jbc.M307759200","article-title":"Identification of conserved domains in Salmonella muenchenflagellin that are essential for its ability to activate TLR5 and to induce an inflammatory response in vitro","volume":"279","author":"Murthy","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Forstneric, V., and Ivicak-Kocjan, K. (2017). The role of the C-terminal D0 domain of flagellin in activation of Toll like receptor 5. PLoS Pathog., 13.","DOI":"10.1371\/journal.ppat.1006574"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.4161\/hv.23809","article-title":"Antigen replacement of domains D2 and D3 in flagellin promotes mucosal IgA production and attenuates flagellin-induced inflammatory response after intranasal immunization","volume":"9","author":"Yang","year":"2013","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Velova, H., Gutowska-Ding, M.W., Burt, D.W., and Vinkler, M. (2018). Toll-like receptor evolution in birds: Gene duplication, pseudogenisation and diversifying selection. Mol. Biol. Evol.","DOI":"10.1093\/molbev\/msy119"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"469","DOI":"10.4161\/hv.26846","article-title":"Safety of an Escherichia coli-expressed bivalent human papillomavirus (types 16 and 18) L1 virus-like particle vaccine: An open-label phase I clinical trial","volume":"10","author":"Hu","year":"2014","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_129","first-page":"1082","article-title":"Expression, purification and immunogenicity analysis of HPV type 18 virus-like particles from Escherichia coli","volume":"25","author":"Xie","year":"2009","journal-title":"Sheng Wu Gong Cheng XueBao"}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/11\/1\/63\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:25:59Z","timestamp":1760185559000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/11\/1\/63"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,15]]},"references-count":129,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,1]]}},"alternative-id":["v11010063"],"URL":"https:\/\/doi.org\/10.3390\/v11010063","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,15]]}}}